[1]
Abdallah Marey Aboshhran, Saeed Ali Alqahtani, Yasser Mesfer Alqhtani, Ahmed Saleh Alharthi, Abdulrahman Hussain Fawwaz Kahl, and Khaled Mohsin Ismail Khormi, “PUBLIC INTEREST IN THE OFF-LABEL USE OF GLUCAGON-LIKE PEPTIDE 1 AGONISTS (OZEMPIC) FOR COSMETIC WEIGHT LOSS‏”, J Popl Ther Clin Pharmacol, vol. 30, no. 2, pp. 745–747, Feb. 2023.